Hedge Fund - Frazier Healthcare Partners
Phathom Pharmaceuticals Inc. (PHAT)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2022 - Q1 (2022-03-31) | $0 | 0% | 0 | $16.15 |
2 | 2021 - Q4 (2021-12-31) | $114,625,000 | 8.82% | 5,827,415 | $23.53 |
3 | 2021 - Q3 (2021-09-30) | $187,060,000 | 14.96% | 5,827,415 | $33.23 |
4 | 2021 - Q2 (2021-06-30) | $197,258,000 | 18.19% | 5,827,415 | $35.81 |
5 | 2021 - Q1 (2021-03-31) | $218,878,000 | 17.55% | 5,827,415 | $41.84 |
6 | 2020 - Q4 (2020-12-31) | $193,587,000 | 14.9% | 5,827,415 | $40.51 |
7 | 2020 - Q3 (2020-09-30) | $213,691,000 | 19.18% | 5,827,415 | $34.63 |
8 | 2020 - Q2 (2020-06-30) | $191,780,000 | 16.84% | 5,827,415 | $38.42 |
9 | 2020 - Q1 (2020-03-31) | $188,080,000 | 21.32% | 7,284,269 | $33.43 |
10 | 2019 - Q4 (2019-12-31) | $226,832,000 | 38.04% | 7,284,269 | $25.13 |
The displayed share prices are average quarterly stock market prices.